Cormorant Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-645,000	Closed	-$3.33M	–	59
2023 Q2	$3.33M	Buy	+645,000	New	+$3.33M	0.19%	53